Evidence map›Paper›PMID 38750131›Full record

ArticleScientific reports2024

CERN-based experiments and Monte-Carlo studies on focused dose delivery with very high energy electron (VHEE) beams for radiotherapy applications.

L Whitmore, R I Mackay, M van Herk, P Korysko, W Farabolini, A Malyzhenkov, R Corsini, R M Jones

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

L WhitmoreDepartment of Physics and Astronomy, University of Manchester, Manchester, M13 9PL, UK.
R I MackayDivision of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
M van HerkDivision of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
P KoryskoDepartment of Physics, University of Oxford, Oxford, UK.
W FaraboliniCERN, 1211, Geneva 23, Switzerland.
A MalyzhenkovCERN, 1211, Geneva 23, Switzerland.
R CorsiniCERN, 1211, Geneva 23, Switzerland.
R M JonesDepartment of Physics and Astronomy, University of Manchester, Manchester, M13 9PL, UK. Roger.Jones@manchester.ac.uk.

Funding

Cancer Research Manchester Centre Research UK RadNet ManchesterEPSRC 2019 EP/R513131/1NIHR Manchester Biomedical Research Centre NIHR203308STFC ST/V001612/1
6 · The paper itself

Abstract

Very High Energy Electron (VHEE) beams are a promising alternative to conventional radiotherapy due to their highly penetrating nature and their applicability as a modality for FLASH (ultra-high dose-rate) radiotherapy. The dose distributions due to VHEE need to be optimised; one option is through the use of quadrupole magnets to focus the beam, reducing the dose to healthy tissue and allowing for targeted dose delivery at conventional or FLASH dose-rates. This paper presents an in depth exploration of the focusing achievable at the current CLEAR (CERN Linear Electron Accelerator for Research) facility, for beam energies >200 MeV. A shorter, more optimal quadrupole setup was also investigated using the TOPAS code in Monte Carlo simulations, with dimensions and beam parameters more appropriate to a clinical situation. This work provides insight into how a focused VHEE radiotherapy beam delivery system might be achieved.

Indexed as

ElectronsMonte Carlo MethodRadiotherapy DosageHumansParticle AcceleratorsRadiotherapyRadiotherapy, High-EnergyRadiotherapy Planning, Computer-Assisted

Identifiers

PMID38750131
PMCPMC11096185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.